In this Cancer Matters podcast, Dr Bill Nelson speaks with thoracic surgeon Dr Stephen Broderick about the latest developments in lung cancer care that have made lung surgery less debilitating and improved patient outcomes.
Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
Jan 27, 2020 No comments
Cancer death rates in the U.S. took the “biggest single-year drop ever,” according to a new report by the American Cancer Society. Improvements in the screening and treatment of lung cancer, the 2nd most common cancer and leading cancer killer, are a main contributor to this positive trend. Julie Brahmer, M.D., Director of the Kimmel […]
Jan 14, 2020 No comments
Patrick Personne was not surprised when his doctor told him he had lung cancer. The 62-year-old had been a smoker for more than 40 years, so when he began feeling ill and developed a nagging cough, lung cancer certainly came to mind. What did surprise him, however, was learning about a new type of treatment […]
Jan 7, 2020 No comments
In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.
Dec 26, 2019 No comments
In the latest On Target podcast, Dr Akila Viswanathan talks with Dr Russell Hales about the thoracic oncology multidisciplinary program available at the Johns Hopkins Kimmel Cancer Center.
Nov 5, 2019 No comments
A new cancer test developed by Johns Hopkins Kimmel Cancer Center scientists screens for seven types of cancer in a completely unique way. DELFI is a new and different kind of cancer screening test. Rather than finding cancer gene mutations or chemical alterations to the DNA, known as epigenetic changes, it detects unique patterns in […]
Jun 11, 2019 1 comment
Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention […]
Nov 16, 2018 No comments
In our next podcast, Dr Bill Nelson talks with Dr Ben Levy, the Clinical Director of Medical Oncology at Sibley Memorial Hospital, Johns Hopkins Medicine, about new treatments for lung cancer patients and the growing cancer center at Sibley. In this preview, Dr Nelson and Dr Levy discuss how immunotherapy drugs are now being used […]
Nov 1, 2018 No comments
Dr Nelson talks with Dr Patrick Forde about his research showing the benefits of using immunotherapy treatments before surgery in lung cancer patients.
Jul 9, 2018 No comments